Education
About Us
Working with TipRanks
Follow Us
Newtopia, Inc. (TSE:NEWU)
:NEWU
NEWU Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume100.00K
Average Volume (3M)0.00
Market Cap
C$866.33K
Enterprise ValueC$14.26M
Total Cash (Recent Filing)C$10.20K
Total Debt (Recent Filing)C$10.80M
Price to Earnings (P/E)―
Beta1.34
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding173,265,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Newtopia News
NEWU FAQ
What was Newtopia, Inc.’s price range in the past 12 months?
Newtopia, Inc. lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Newtopia, Inc.’s market cap?
Newtopia, Inc.’s market cap is C$866.33K.
When is Newtopia, Inc.’s upcoming earnings report date?
Newtopia, Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 96 days.
How were Newtopia, Inc.’s earnings last quarter?
Currently, no data Available
Is Newtopia, Inc. overvalued?
According to Wall Street analysts Newtopia, Inc.’s price is currently Overvalued.
Does Newtopia, Inc. pay dividends?
Newtopia, Inc. does not currently pay dividends.
What is Newtopia, Inc.’s EPS estimate?
Newtopia, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Newtopia, Inc. have?
Newtopia, Inc. has 173,265,300 shares outstanding.
What happened to Newtopia, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Newtopia, Inc.?
Currently, no hedge funds are holding shares in TSE:NEWU
Company Description
Newtopia, Inc.
Newtopia (NEWU) is a company operating in the health and wellness sector, focusing on personalized health improvement programs. It offers innovative solutions designed to enhance the health and well-being of individuals through tailored lifestyle interventions. The company's core services include digital health coaching, genetic testing, and personalized wellness plans aimed at preventing chronic diseases and improving overall health outcomes.
Technical Analysis
HLS Therapeutics Inc
―
Neo Performance Materials Inc
―
WELL Health Technologies Corp
―
Ownership Overview
13.58% Insiders
―
Mutual Funds
― Other Institutional Investors
86.42% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---